SMOLDERING MULTIPLE MYELOMA
Clinical trials for SMOLDERING MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new SMOLDERING MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for SMOLDERING MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a bone drug stop smoldering myeloma in its tracks?
Disease control CompletedThis study tested the safety of denosumab, a drug usually used for bone health, in 20 people with smoldering multiple myeloma (a pre-cancer condition). The goal was to see if the drug could lower their risk of developing active multiple myeloma. Researchers tracked changes in ris…
Matched conditions: SMOLDERING MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Disease control
Last updated May 17, 2026 04:32 UTC
-
Scientists dig into medical records to predict who gets Full-Blown myeloma
Knowledge-focused CompletedThis study looked back at the medical records of 431 people with smoldering multiple myeloma (SMM), a pre-cancer condition. The goal was to see how the disease behaves in real life, especially for those at high risk of progressing to active multiple myeloma. Researchers tracked t…
Matched conditions: SMOLDERING MULTIPLE MYELOMA
Sponsor: Janssen-Cilag Ltd. • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC
-
New scans aim to catch myeloma before it starts
Knowledge-focused CompletedThis study looked at whether newer imaging techniques can better detect when early blood disorders (MGUS and smoldering myeloma) turn into active multiple myeloma. Thirty-one adults with these conditions received three types of scans: a standard PET/CT, an experimental PET/CT usi…
Matched conditions: SMOLDERING MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC